Isao Ohsawa
Overview
Explore the profile of Isao Ohsawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyake N, Osuka S, Ohsawa I, Tonoike T, Uno T, Tsuzuki K, et al.
Reprod Med Biol
. 2024 Nov;
23(1):e12615.
PMID: 39529992
Purpose: Polycystic ovary syndrome (PCOS) significantly affects women. This study investigated the association between serum anti-Müllerian hormone (AMH) levels and menstrual cycle disorders, and AMH for PCOS in a general...
2.
Hamada C, Kuwamura J, Fukui M, Ohsawa I, Nakamura Y, Suzuki S, et al.
Clin Exp Nephrol
. 2024 Oct;
29(3):322-331.
PMID: 39436585
Background: The ability to access health and medical information have implications for prognosis and quality of life. This study investigated the current communication environment and health literacy in chronic hemodialysis...
3.
Ohsawa I, Onuki A, Oka F, Matsuoka Y, Makita Y, Kobayashi T, et al.
BMC Nephrol
. 2024 Jun;
25(1):188.
PMID: 38831308
Background: Long-term enzyme replacement therapy (ERT) may improve prognosis in the patients with Fabry disease (FD), however, detail psychosocial burden has not been focused on long life expectancy. We experienced...
4.
Honda D, Hide M, Fukuda T, Koga K, Morita E, Moriwaki S, et al.
World Allergy Organ J
. 2024 Mar;
17(3):100882.
PMID: 38445295
Background: Berotralstat is a once-daily oral inhibitor of plasma kallikrein for the prophylaxis of hereditary angioedema (HAE) in patients ≥12 years. APeX-J aimed to evaluate the efficacy and safety of...
5.
Honda D, Ohsawa I, Aizawa M, Miyamoto I, Uzawa K, Asanuma K
Cureus
. 2023 Oct;
15(10):e46869.
PMID: 37841987
Hereditary angioedema (HAE), caused by C1-inhibitor (C1-INH) deficiency or dysfunction, is a rare and potentially life-threatening disease that leads to unpredictable recurrent attacks of angioedema in localized regions, including the...
6.
Honda D, Ohsawa I, Miyata T, Ozaki M, Aizawa M, Tomino Y, et al.
Allergol Int
. 2023 Aug;
73(1):174-176.
PMID: 37598072
No abstract available.
7.
Hide M, Ohsawa I, Nurse C, Yu M
J Dermatol
. 2023 Aug;
50(11):1381-1391.
PMID: 37574953
The safety and efficacy of lanadelumab for the prevention of hereditary angioedema (HAE) attacks have not been studied in Japanese patients. We report outcomes from a phase 3, multicenter, open-label...
8.
Koshida T, Gohda T, Sugimoto T, Asahara T, Asao R, Ohsawa I, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511232
The composition of the gut microbiome is altered in patients with chronic kidney disease (CKD). Dysbiosis leads to decreased levels of stool organic acids (OAs) and systemic inflammation, followed by...
9.
Honda D, Ohsawa I, Aizawa M, Tomino Y, Asanuma K
Allergy Asthma Clin Immunol
. 2023 May;
19(1):42.
PMID: 37194078
Background: Hereditary angioedema (HAE), which is caused by C1-inhibitor (C1-INH) deficiency or dysfunction, is a rare and potentially life-threatening disease. In patients with HAE, excess production of bradykinin causes acute...
10.
Yamamoto B, Honda D, Ohsawa I, Iwamoto K, Horiuchi T, Fukunaga A, et al.
Intractable Rare Dis Res
. 2023 Mar;
12(1):35-44.
PMID: 36873666
Hereditary angioedema (HAE) is a potentially life-threatening rare disease, which is mainly caused by the deficiency or dysfunction of C1-esterase inhibitor, and characterized by spontaneous, recurrent episodes of edema in...